Tagged: OP-Ed

1

Yet Another FDA Failure: PatientsLikeMe®

Why would the FDA make such an outrageous decision to enter into an unprecedented agreement to monitor post-marketing drug surveillance with a private company run by ex-pharmaceutical executives? The FDA would be better off looking at its FAERS data. If they did, they would see drug signals that they have ignored, especially for FQ’s.

Why I Have Withdrawn Support From The QVF

It is my regret to inform those reading, as a founding member and first director of the Quinolone Vigilance Foundation (QVF), I am forced to withdraw my support of the QVF and have no confidence in its current leadership.